Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2651-2655

  Zhou, Jie ^a   Zou, Lirong ^a   Zhang, Xin ^a   Liao, Jiazheng ^a   Ni, Hanzhong ^a   Hou, Nianmei ^a   Wang, Yajing ^a   Li, Hui ^a   Wu, Jie ^a   Jonges, Marcel ^b   Meijer, Adam ^b   Koopmans, Marion ^b   Ke, Changwen ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; ANTIVIRUS AGENT; OSELTAMIVIR; VIRUS SIALIDASE;

ARTICLE; CHINA; CLADISTICS; CONTROLLED STUDY; DRUG USE; ENZYME INHIBITION; FLUORESCENCE; GENE SEQUENCE; GENETIC REASSORTMENT; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEASONAL INFLUENZA A (H1N1) 2009 VIRUS; VIRUS RESISTANCE;

ADAMANTANE; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; GENOTYPE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; OSELTAMIVIR; SEQUENCE ANALYSIS, DNA; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

ORTHOMYXOVIRIDAE;

EID: 79959858656     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00535-11     Document Type: Article

References (27)

1. Bao, Y., et al. 2008. The influenza virus resource at the National Center for Biotechnology Information. J. Virol. 82:596-601.
2. Baranovich, T., et al. 2010. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J. Clin. Virol. 47:23-28.
3. Bauer, K., M. Richter, P. Wutzler, and M. Schmidtke. 2009. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006. Antiviral Res. 82:34-41.
4. Bright, R. A., et al. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175-1181. (Pubitemid 41393595)
5. Bright, R. A., D. K. Shay, B. Shu, N. J. Cox, and A. I. Klimov. 2006. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295:891-894.
6. Chen, H., et al. 2009. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg. Infect. Dis. 15:1970-1972.
7. Cheng, P. K., et al. 2009. Oseltamivir- and amantadine-resistant influenza viruses A (H1N1). Emerg. Infect. Dis. 15:966-968.
8. Cheng, P. K., et al. Oseltamivir- and amantadine-resistant influenza virus A (H1N1). Emerg. Infect. Dis. 16:155-156.
9. Deyde, V. M., et al. 2007. Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide. J. Infect. Dis. 196:249-257.
10. Gubareva, L. V., L. Kaiser, M. N. Matrosovich, Y. Soo-Hoo, and F. G. Hayden. 2001. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183:523-531.
11. Kramarz, P., D. Monnet, A. Nicoll, C. Yilmaz, and B. Ciancio. 2009. Use of oseltamivir in 12 European countries between 2002 and 2007-lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. Euro Surveill. 14(5):pii=19112.
12. Lackenby, A., et al. 2008. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill. 13(5):pii=8026.
13. Leung, T. W. C., A. L. S. Tai, P. K. C. Cheng, M. S. Y. Kong, and W. Lim. 2009. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. J. Clin. Virol. 46:298-299.
14. Meijer, A., A. Lackenby, O. Hungnes, B. Lina, S. van-der-Werf, B. Schweiger, M. Opp, J. Paget, J. van-de-Kassteele, A. Hay, and M. Zambon. 2009. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis. 15:552-560.
15. Monto, A. S., et al. 2006. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother. 50:2395-2402.
16. Moscona, A. 2009. Global transmission of oseltamivir-resistant influenza. N. Engl. J. Med. 360:953-956.
17. Reference deleted.
18. Nelson, M. I., L. Simonsen, C. Viboud, M. A. Miller, and E. C. Holmes. 2009. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology 388:270-278.
19. Potier, M., L. Mameli, M. Belisle, L. Dallaire, and S. B. Melancon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl- α-DN-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
20. Russell, C. A., et al. 2008. The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340-346. (Pubitemid 351555652)
21. Sheu, T. G., et al. 2008. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52:3284-3292.
22. Sheu, T. G., et al. Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. J. Infect. Dis. 203:13-17.
23. Simonsen, L. 1999. The global impact of influenza on morbidity and mortality. Vaccine 17:S3-S10. (Pubitemid 29366926)
24. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596.
25. Ujike, M., et al. 2010. Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerg. Infect. Dis. 16:926-935.
26. Wang, B., et al. 2010. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 87:16-21.
27. Zaraket, H., et al. 2010. Genetic makeup of amantadine-resistant and oseltamivir- resistant human influenza A/H1N1 viruses. J. Clin. Microbiol. 48: 1085-1092.